The entire SENTÉ team is excited to partner with Skinuva and provide our physician network with a truly innovative scar minimizing solution backed by compelling clinical evidence. We look forward to integrating Skinuva Scar Cream in our portfolio of skin care products to serve the needs of patients.
BEVERLY HILLS, Calif. (PRWEB) January 20, 2021
Skinuva® is excited to announce its partnership with SENTÉ®, a specialty aesthetics company and the exclusive US Professional Sales Partner of the revolutionary scar cream Skinuva® Scar.
Since the introduction of silicone cream in the late 1990's there have been limited advancements in the topical scar therapy industry. Skinuva Scar is a patented, physician-designed scar cream clinically proven to be 2x more effective than regular silicone cream in improving the appearance of scars. Supported by five publications in peer-reviewed medical literature, Skinuva Scar uses highly selective growth factors to provide fantastic results in minimal time.
“The entire SENTÉ team is excited to partner with Skinuva and provide our physician network with a truly innovative scar minimizing solution backed by compelling clinical evidence. We look forward to integrating Skinuva Scar Cream in our portfolio of skin care products to serve the needs of patients post surgery,” said Laurent Combredet, CEO of SENTÉ.
SENTÉ is the market leader of innovative skincare treatments in the realms of Dermatology and Plastic Surgery, making it the ideal partner for the most innovative scar treatment product available. As of January 2021, SENTÉ customers across the United States will be able to order Skinuva Scar in addition to SENTÉ’s leading anti-aging products.
Skinuva line of products provide the most advanced topical therapy yet to be formulated for scars (Skinuva® Scar) and hyperpigmentation (Skinuva® Brite) using growth factor technology along with other scientifically proven key ingredients. Launched in 2018 and based in Beverly Hills, CA, more information can be found at Skinuva.com.
For general inquiries about Skinuva, email email@example.com or call (310) 873-3912.
For more information regarding Skinuva available through SENTÉ, email firstname.lastname@example.org.